Disclosure statement:
Qualified on the content I am responsible for because: I have considerable experience from U.S. Government positions (FDA, SAMHSA) in domestic and international opioid epidemiology, pharmacology, and treatment interventions for dependence treatment. This includes recent experience with the consequences associated with prescription opioid abuse, diversion, dependence, and addiction.
Since February, 2013, I became employed by Reckitt Benckiser Pharmaceuticals. This company manufactures and distributes the opioid dependence treatment medication Suboxone.
Any relevant financial relationships? Yes
| Name of Organization | Clinical/Research Area | Type of relationship |
|---|---|---|
| Reckitt Benckiser Pharmaceuticals | Opioid Dependence Treatment | Employment (includes retainer) |
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.